Tag

Senores Pharmaceuticals Limited

2 articles

Senores Pharma May 25 Analyst Meetings

Senores Pharmaceuticals intimates BSE and NSE of its scheduled analyst and institutional investor meetings on May 25, 2026. The physical meetings, hosted by Ambit Capital in Mumbai, will involve group

Senores Pharmaceuticals FY26 Revenue Up 62% PAT 108%

Senores Pharmaceuticals reported strong FY26 results with revenue growth of 62% to INR664 crore and PAT growth of 108% to INR122 crore. Management provided FY27 guidance for 30-40% revenue growth and